Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Xiaochen Shu"'
Autor:
Junlan Qiu, Yirong Xin, Jiazhen Yao, Lingkai Xu, Fang Meng, Lin Feng, Xiaochen Shu, Zhixiang Zhuang
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 854-864 (2023)
Background: A fundamental principle of pain management is to determine the distribution and causes of pain. However, relevant data among postoperative cancer patients based on a large amount of data remain sparse. Objective: We aimed to investigate t
Externí odkaz:
https://doaj.org/article/39563f124df64f09a54bbbc36e8a950e
Autor:
Zhenjiang Bai, Qing Li, Qinghui Chen, Changming Niu, Yu Wei, Hanpeng Huang, Wei Zhao, Nian Chen, Xin Yao, Qiang Zhang, Chuanyong Mu, Jian Feng, Chuanlong Zhu, Zhuo Li, Ming Ding, Binhui Feng, Chaochao Jin, Xiang Lu, Yi Yang, Shuiyan Wu, Xiaochen Shu, Lifang Hu, Haibo Qiu, YingZi Huang
Publikováno v:
Journal of Intensive Medicine, Vol 2, Iss 1, Pp 32-38 (2022)
Background: There have been many studies about coronavirus disease 2019 (COVID-19), but the clinical significance of quantitative serum severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)-specific IgM and IgG levels of COVID-19 patients have
Externí odkaz:
https://doaj.org/article/7349f54728d745ee89f445fc7c1e78d5
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Objectives Synergism between the metabolic syndrome (MetSyn) components and cancer incidence still remains inconclusive. We aimed to investigate the unique or joint role of MetSyn components in cancer onset.Design We conducted a prospective nested ca
Externí odkaz:
https://doaj.org/article/49406f6c05a64987a9236126f13278f8
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Externí odkaz:
https://doaj.org/article/faa1d3f50792489ab5a82c76de1f62e2
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Background: Immune checkpoint inhibitors (ICIs) have made a significant breakthrough in the treatment of solid tumors; however, their use also generates unique immune-related adverse effects (irAEs). Here, we performed a systematic review and meta-an
Externí odkaz:
https://doaj.org/article/43e3c6f406ef4a71a6fed0fbda95d53d
Autor:
Jie Zeng MSc, Xuhui Zhang MD, Gregory Y. H. Lip MD, Xiaochen Shu MD, Lehana Thabane PhD, Junzhang Tian MD, Guowei Li PhD, MSc, MBBS
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Efficacy and safety of direct oral anticoagulants (DOACs) for preventing primary and recurrent venous thromboembolism (VTE) in patients with cancer remain unclear. In this study, we conducted a systematic review to summarize the most up-to-date evide
Externí odkaz:
https://doaj.org/article/c654cb7c261f4500a74d2da69f805886
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39523 (2012)
BackgroundAcute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are common early-onset malignancies. Their causes are largely unknown but infectious etiology has been implicated. Type 1 diabetes (T1D) is an autoimmune disease for which
Externí odkaz:
https://doaj.org/article/40b9a4f8ab7744f6b7d4cc6a9a6eea80
Autor:
Xiaohong, Chen, Jiazhen, Yao, Yirong, Xin, Genshan, Ma, Yan, Yu, Yuan, Yang, Xiaochen, Shu, Hanzhong, Cao
Publikováno v:
Pain and Therapy. 12:275-292
Postoperative cancer pain imposes severe physical and psychological problems. We aimed to investigate the pain experiences of patients with cancer after surgery, analyze the impact of infusion volume by patient-controlled analgesia (PCA), and explore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a14ccbc1de7d582aa251765c7fc7c8
https://doi.org/10.1007/s40122-022-00459-w
https://doi.org/10.1007/s40122-022-00459-w
Publikováno v:
European Journal of Clinical Investigation. 53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::699658a4be2fb96b3bd423cc4fb96806
https://doi.org/10.1111/eci.13971
https://doi.org/10.1111/eci.13971
Autor:
Qingting Feng, Xiaochen Shu, Fang Meng, Shun Lu, Yiqing Jiang, Lingkai Xu, Ziwei Huang, Junlan Qiu, Tao Wen, Lin Li
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The prevalence of multi-morbidities with colorectal cancer (CRC) is known to be increasing. Particularly prognosis of CRC patients co-diagnosed with metabolic syndrome (MetSyn) was largely unknown. We aimed to examine the death risk of CRC pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de62ba5428009e9a767d01311120f6c3
http://europepmc.org/articles/PMC8291199
http://europepmc.org/articles/PMC8291199